Cencora Inc (N:COR)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
See Regulatory Filings on SEC
Company Contact
Address: 1 West First Avenue
Tel: 1-610-727-3693
Website: https://www.cencora.com
IR: See website
Key People
Steven H. Collis
Chairman of the Board, President, Chief Executive Officer
James F. Cleary
Chief Financial Officer, Executive Vice President
Robert P. Mauch
Chief Operating Officer, Executive Vice President
Silvana Battaglia
Chief Human Resource Officer, Executive Vice President
Gina K. Clark
Executive Vice President, Chief Communications and Administration Officer
Elizabeth S. Campbell
Executive Vice President and Chief Legal Officer
Leslie E. Donato
Executive Vice President and Chief Strategy Officer
Business Overview
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Financial Overview
For the six months ended 31 March 2024, Cencora Inc revenues increased 11% to $140.67B. Net income increased 12% to $1.02B. Revenues reflect Human Health segment increase of 12% to $123.88B, Alliance Healthcare segment increase of 4% to $11.48B, Other Healthcare Solutions segment increase of 15% to $2.71B. Net income benefited from U.S. Healthcare Solutions segment income increase of 16% to $1.54B.
Employees: 42,000 as of Sep 30, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $50,491M as of Mar 31, 2024
Annual revenue (TTM): $276,537M as of Mar 31, 2024
EBITDA (TTM): $3,938M as of Mar 31, 2024
Net annual income (TTM): $1,852M as of Mar 31, 2024
Free cash flow (TTM): $1,702M as of Mar 31, 2024
Net Debt Last Fiscal Year: $3,181M as of Mar 31, 2024
Shares outstanding: 199,451,791 as of Apr 26, 2024
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.